Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1 Journal Article


Authors: Chesler, L.; Golde, D. W.; Bersch, N.; Johnson, M. D.
Article Title: Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1
Abstract: Tissue inhibitor of metalloproteinases-1 (TIMP-1), the major physiological matrix metalloproteinase inhibitor and a potent antimetastatic factor, also stimulates the growth of erythroid progenitors (erythroid-potentiating activity). We analyzed the relationship between the growth factor activity and protease inhibition by preparing purified TIMP-1 ''knock-out'' proteins lacking in vitro antiproteolytic activity. The growth-stimulatory effect of these N-terminal TIMP-1 point mutants, as tested in an in vitro assay using erythroid precursors (erythroid burst-forming units) was equal to that of unmutated TIMP-1. A fully antiproteolytic C-terminal TIMP-1 truncation also stimulated growth in the erythroid burst-forming unit assay, The results indicate that the influence of TIMP-1 on erythroid precursor growth is independent of its ability to inhibit metalloproteinases. TIMP-1 is analogous to proteins that have both proteolytic and growth factor activity, such as plasmin, thrombin, and urokinase. However, TIMP-1 is novel in this regard because It is a metalloproteinase inhibitor. We show that the antiproteolytic and growth factor activities of the TIMP-1 molecule are physically and functionally distinct. (C) 1995 by The American Society of Hematology.
Keywords: fibroblasts; crystallization; collagenase; invasion; terminal domain; growth-factor; matrix; human; b16-f10 melanoma-cells; x-ray analysis; timp-2
Journal Title: Blood
Volume: 86
Issue: 12
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1995-12-18
Start Page: 4506
End Page: 4515
Language: English
ACCESSION: WOS:A1995TK47900015
PROVIDER: wos
PUBMED: 8541540
DOI: 10.1182/blood.V86.12.4506.bloodjournal86124506
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Golde
    127 Golde